Promedior
Pioneering advanced therapies to heal fibrotic and inflammatory diseases at their source, enhancing precision and minimizing systemic risks
General Information
Get notified when Promedior moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Promedior
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
About Promedior
Taxonomy: biopharmaceutical, drug discovery, therapeutics, fibrotic diseases, inflammatory diseases, clinical-stage, monocyte-derived cell populations, immunotherapy, tissue healing, precision medicine, autoimmune conditions, eye diseases, lung diseases, kidney diseases, novel therapeutics
Funding Rounds & Investors (7)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | •••••• | 1 |
|
01 Jan 2019 |
| Series D | •••••• | 7 |
|
15 Oct 2012 |
| Series D | •••••• | 6 |
|
07 Mar 2012 |
| Debt Financing | •••••• | - | 17 Oct 2011 | |
| Series C | •••••• | 1 |
|
17 Mar 2010 |
Promedior Alternatives & Competitors
Developing innovative precision therapies for the treatment of inflammatory and fibrotic diseases
Creating innovative solutions for targeted treatment of immunological and inflammatory diseases from...
Clinical-stage biopharmaceutical company focused on the development of structurally engineered fatty...
FAQ About Promedior
Don't just browse. Track.
Signal Tracker monitors Promedior and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.